302 related articles for article (PubMed ID: 17965779)
1. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
[TBL] [Abstract][Full Text] [Related]
2. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.
Li HH; Kedar V; Zhang C; McDonough H; Arya R; Wang DZ; Patterson C
J Clin Invest; 2004 Oct; 114(8):1058-71. PubMed ID: 15489953
[TBL] [Abstract][Full Text] [Related]
3. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
Skurk C; Izumiya Y; Maatz H; Razeghi P; Shiojima I; Sandri M; Sato K; Zeng L; Schiekofer S; Pimentel D; Lecker S; Taegtmeyer H; Goldberg AL; Walsh K
J Biol Chem; 2005 May; 280(21):20814-23. PubMed ID: 15781459
[TBL] [Abstract][Full Text] [Related]
4. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
[TBL] [Abstract][Full Text] [Related]
5. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
6. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.
Ni YG; Berenji K; Wang N; Oh M; Sachan N; Dey A; Cheng J; Lu G; Morris DJ; Castrillon DH; Gerard RD; Rothermel BA; Hill JA
Circulation; 2006 Sep; 114(11):1159-68. PubMed ID: 16952979
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
8. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
Baskin KK; Rodriguez MR; Kansara S; Chen W; Carranza S; Frazier OH; Glass DJ; Taegtmeyer H
J Mol Cell Cardiol; 2014 Jul; 72():168-76. PubMed ID: 24650875
[TBL] [Abstract][Full Text] [Related]
9. You spin me round: MaFBx/Atrogin-1 feeds forward on FOXO transcription factors (like a record).
Schisler JC; Willis MS; Patterson C
Cell Cycle; 2008 Feb; 7(4):440-3. PubMed ID: 18235241
[TBL] [Abstract][Full Text] [Related]
10. Stability of F-box protein atrogin-1 is regulated by p38 mitogen-activated protein kinase pathway in cardiac H9c2 cells.
Li JJ; Zhang TP; Meng Y; Du J; Li HH
Cell Physiol Biochem; 2011; 27(5):463-70. PubMed ID: 21691063
[TBL] [Abstract][Full Text] [Related]
11. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
12. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
13. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.
Léger B; Vergani L; Sorarù G; Hespel P; Derave W; Gobelet C; D'Ascenzio C; Angelini C; Russell AP
FASEB J; 2006 Mar; 20(3):583-5. PubMed ID: 16507768
[TBL] [Abstract][Full Text] [Related]
14. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
[TBL] [Abstract][Full Text] [Related]
15. Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo.
Mota R; Parry TL; Yates CC; Qiang Z; Eaton SC; Mwiza JM; Tulasi D; Schisler JC; Patterson C; Zaglia T; Sandri M; Willis MS
Am J Pathol; 2018 Jul; 188(7):1676-1692. PubMed ID: 29758183
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.
Nakao R; Hirasaka K; Goto J; Ishidoh K; Yamada C; Ohno A; Okumura Y; Nonaka I; Yasutomo K; Baldwin KM; Kominami E; Higashibata A; Nagano K; Tanaka K; Yasui N; Mills EM; Takeda S; Nikawa T
Mol Cell Biol; 2009 Sep; 29(17):4798-811. PubMed ID: 19546233
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
18. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
19. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation.
Xie P; Guo S; Fan Y; Zhang H; Gu D; Li H
J Biol Chem; 2009 Feb; 284(9):5488-96. PubMed ID: 19117950
[TBL] [Abstract][Full Text] [Related]
20. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
